What Challenges Exist in Targeting Kinesins for Cancer Therapy?
One of the primary challenges is the development of drug resistance. Cancer cells can develop mechanisms to bypass the action of kinesin inhibitors, leading to treatment failure. Additionally, the toxicity and side effects associated with these inhibitors need to be carefully managed to ensure patient safety.
